Halifax, Nova Scotia — (Newsfile Corp. – November 27, 2023) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce that it has closed its private placement that was announced on October 18, 2023 with the issuance of 3,750,000 shares at $0.20 per share and 1,875,000 common share purchase warrants […]
Halifax, Nova Scotia – (Newsfile Corp. – October 18, 2023) – Sona Nanotech Inc. (CSE: SONA, OTCQB: SNANF) (the “Company”, “Sona”) is pleased to announce that it plans to raise up to $750,000 through a brokered private placement (the “Financing”) of up to 3,750,000 units of Sona (each, a “Unit”) at $0.20 per Unit (the “Offering Price”). […]
Halifax, Nova Scotia — (Newsfile Corp. – October 12, 2023) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”), a nanotechnology life sciences company with proprietary manufacturing technology for biocompatible gold nanorods (“GNRs”), is pleased to provide an update on the status of its current operating activities, notably the development of its Targeted Hyperthermia […]
Halifax, Nova Scotia — (Newsfile Corp. – September 11, 2023) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce an innovative research initiative to be undertaken with The Giacomantonio Immuno-Oncology Research Group (the “Research Group”). This study aims to evaluate the efficacy of Sona’s Targeted Hyperthermia Therapy (“THT”) technology […]
Halifax, Nova Scotia — (Newsfile Corp. – September 5, 2023) – Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce it has partnered with EXCITE International (“EXCITE”), a global network of senior specialist physicians, payors, health systems, and end-users, to help guide the development of Sona’s Targeted Hyperthermia Therapy. […]
Halifax, Nova Scotia — (Newsfile Corp. – June 8, 2023) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce that it has received the third set of results of an independent assessment of its proprietary gold nanorod nanoparticles from the U.S. National Cancer Institute’s Nanotechnology Characterization Laboratory (“NCL”). In […]
Halifax, Nova Scotia — (Newsfile Corp. – May 30, 2023) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”), a nanotechnology company developing pre-clinical Targeted Hyperthermia Therapy (“THT”) for colorectal cancer, is pleased to announce the selection of Minnetronix Medical to engineer the next generation of its infrared light device. The device will […]
Halifax, Nova Scotia — (Newsfile Corp. – May 18, 2023) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”), a nanotechnology company developing pre-clinical Targeted Hyperthermia Therapy for colorectal cancer, is pleased to announce the election as chair of the board, Mr. Mark Lievonen, CM, who joined the board of Sona in […]
Halifax, Nova Scotia — (Newsfile Corp. – May 9, 2023) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce that an agreement for the sale of its non-core interest in the Crescent Lake lithium property located in Ontario, Canada (“Property”) to an arm’s length party, Midex Resources Ltd. […]
Halifax, Nova Scotia — (Newsfile Corp. – April 17, 2023) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce that it has received the second set of results of an independent assessment of its proprietary gold nanorod nanoparticles from the U.S. National Cancer Institute’s Nanotechnology Characterization Laboratory (“NCL”). […]
- 1
- 2